PubMed Health⌕ Search

PubMed · 8889559

In-line blood/solution warmers.

Abstract

In-line blood/solution warmers are used in many clinical procedures to warm refrigerated and room temperature fluids as they are infused into the patient. Warming fluids such as whole blood, blood products, intravenous (IV) solutions, and irrigation solutions helps to maintain the patient's core body temperature, thus minimizing adverse thermal reactions (e.g., hypothermia). In this study, we evaluated nine in-line blood/solution warmers from seven manufacturers. We tested these systems' performance and safety, human factors design, and quality of construction, focusing on how well the devices warm fluids over a variety of infusion rates common in clinical use. We rated each system according to the clinical application base for which it is primarily intended-routine-flow procedures (i.e., those that require low or moderate flow rates) or high-flow procedures. Of the six systems in the routine-flow category, we rated only two units Acceptable; the remaining four were rated Acceptable-Not Recommended because they could not warm fluids to the same temperature level as the Acceptable units. We rated all three of the systems in the high-flow category Acceptable. Within each of these rating groups, we ranked units according to the results of our testing, as well as the results of a life-cycle cost analysis that we performed. In the Technology Overview, we discuss the clinical need for blood/solution warming and outline the debate over whether and when in-line warming devices should be used. Also, we describe the technologies used in these devices, as well as the safety issues associated with their use. The Selection, Purchasing, and Use Guide at the end of the Evaluation provides guidance to help facilities (1) assess their blood/solution warming needs, (2) choose the systems that will best meet their needs, and (3) use these systems effectively. This study also includes the supplementary article, "Maximum Blood Warming Temperature-How Hot Is Too Hot?"

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

1996. In-line blood/solution warmers.. https://pubmed.ncbi.nlm.nih.gov/8889559/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The role of vertical transmission and health care-related factors in HIV infection of children: a community study in rural Uganda.

OBJECTIVES: To determine the probable route of transmission of HIV to children aged 12 years or younger in a rural area of Uganda from 1999 through 2000 and to examine associations between HIV infection and health care-related variables. METHODS: The HIV infections status for 6991 children was determined from 1 round of an ongoing population surveillance system, and the reported numbers of injections in the past year and blood transfusions were determined for 5922 of these children based on a medical questionnaire. Data from the surveillance system and from an additional survey were used to assess the potential for vertical infection from a mother to her child. RESULTS: The HIV prevalence among children was 0.4%. Of 23 definite and 4 probable cases of HIV infection in children, vertical transmission was not possible for 1 case, not likely for another case, and possibly not vertical for another case. The population-attributable fraction for vertical transmission was between 90% and 94%. Large numbers of injections in the past year and ever having a blood transfusion were only associated with HIV infection in children exposed to vertical transmission. CONCLUSIONS: Up to 10% of HIV infections in children in the study area were not attributable to vertical transmission, and thus were possibly attributable to iatrogenic transmission. Associations seen between health care-related variables and HIV were likely to be attributable to treatment for AIDS-related illness in children infected vertically.

Blood Transfusion↗

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

This paper describes the trends in haematopoietic stem cell transplantation (HSCT) activity for children in Europe over the last three decades. We analysed 31,713 consecutive paediatric HSCTs reported by the European Group for Blood and Marrow Transplantation (EBMT) centres between 1970 and 2002. Data were taken from the EBMT registry and were compared according to period and centre category (paediatric or combined). Since 1996, there has been a significant increase in the number of HSCTs performed exclusively by paediatric centres, as well as in the number of alternative donor HSCTs, and in the use of peripheral blood stem cells (P<0.0001). The number of allogeneic HSCTs (allo-HSCTs) for acute lymphoblastic leukaemia, acute myeloblastic leukaemia and chronic myeloid leukaemia remained stable, whereas it increased for myelodysplastic syndromes and lymphomas, and decreased significantly for non-malignant diseases (P<0.0001). Multivariate analysis showed that younger age, human leukocyte antigen genoidentical donors, HSCT performed after 1996 and transplant centres performing more than 10 allo-HSCT/year were all associated with decreased transplant-related mortality (TRM) (P<0.0001). The number of autologus HSCTs (auto-HSCTs) for acute leukaemia decreased significantly, whereas it increased for solid tumours (P<0.0001). Multivariate analysis showed that both auto-HSCT performed before 1996 and paediatric solid tumours (P<0.0001) had higher TRM. Indications for paediatric HSCT have changed considerably during the last seven years. These changes provide tools for decision making in health-care planning and counselling.

Blood Transfusion↗